The Power of Personalized Quantitative Imaging
With LDAi, descriptive terminology such as ‘mild’ or ‘moderate’ is no longer acceptable to accurately assess COPD or emphysema.
For Your Practice
LDAi is a fully automated solution delivering quantitative analysis and 3D visualization to the patient study in PACS. LDAi includes Imbio Noise Reduction Technology (NRT) to aid quantification and visualization of low dose scans, and also includes Imbio’s Patient LungMap™ report to aid smoking cessation counseling.
Suggested use cases for LDAi
- Lung Cancer Screening programs and smoking cessation counseling
- Population screening for emphysema/COPD on all chest CT scans
- Patient selection for endobronchial valves
- Lung Health Programs
- Clinical Trials